Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20407035

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2010 Jul 8
First author
De Moerloose B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2010 Oct;7(10):552. doi: 10.1038/nrclinonc.2010.148.
    note
    Source null
    related pmid
    20922833
    relationship
    Comment in

Authors and identifiers

  1. name
    De Moerloose B
    type
    Author
  2. name
    Suciu S
    type
    Author
  3. name
    Bertrand Y
    type
    Author
  4. name
    Mazingue F
    type
    Author
  5. name
    Robert A
    type
    Author
  6. name
    Uyttebroeck A
    type
    Author
  7. name
    Yakouben K
    type
    Author
  8. name
    Ferster A
    type
    Author
  9. name
    Margueritte G
    type
    Author
  10. name
    Lutz P
    type
    Author
  11. name
    Munzer M
    type
    Author
  12. name
    Sirvent N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    De Moerloose B
    type
    Author
  2. name
    Suciu S
    type
    Author
  3. name
    Bertrand Y
    type
    Author
  4. name
    Mazingue F
    type
    Author
  5. name
    Robert A
    type
    Author
  6. name
    Uyttebroeck A
    type
    Author
  7. name
    Yakouben K
    type
    Author
  8. name
    Ferster A
    type
    Author
  9. name
    Margueritte G
    type
    Author
  10. name
    Lutz P
    type
    Author
  11. name
    Munzer M
    type
    Author
  12. name
    Sirvent N
    type
    Author
bibliography ids
  1. nci-bib-2508a0e9cb2897bfe5e2195f
book metadata
content sha256
f190cb90803343d6d1924562a470e0c37e099b8c99a832888cac8226cd4215c8
document type
citation
dois
  1. 10.1182/blood-2009-10-247965
electronic publication date
display
2010 Apr 20
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20407035
immutable id
pubmed:20407035@f190cb90803343d6d1924562a470e0c37e099b8c99a832888cac8226cd4215c8
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
1
name
Blood
nlm unique id
7603509
pages
36-44
volume
116
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2010 Oct;7(10):552. doi: 10.1038/nrclinonc.2010.148.
    note
    Source null
    related pmid
    20922833
    relationship
    Comment in
outcomes validated
false
pmid
20407035
provenance
batch id
bce21fa556c206e375c2
provider
NCBI PubMed ESummary
record sha256
26bc4a9688648131d45fb1f69113d1cf490386316b41f079a902c3865cbe1b0b
response sha256
280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
retrieved at
2026-09-09T23:46:33.526275+00:00
publication date
display
2010 Jul 8
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20407035/
title
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Preserved source evidence · Not medical advice